Pfizer vaccine can be stored in normal medical freezers
Global cases have reached 110,562,484, according to Johns Hopkins University in Baltimore
/NOVOSTIVL/ Pfizer plans to double the weekly supply of its COVID-19 vaccine in the U.S. in the next few weeks from the current average of about 5 million doses, according to the drugmaker's CEO.
Albert Bourla cited increased batch size and yield, as well as more efficient lab test methods, in reducing the time required to make the vaccine from 110 days to 60.
The Pfizer-BioNTech COVID-19 vaccine can be stored at normal medical freezer temperatures for up to two weeks, according to data the companies submitted to U.S. regulators, rather than the previously required conditions of minus 60 C to minus 80 C.
BioNTech CEO Ugur Sahin says the company continues to develop new formulations to make the vaccine "even easier to transport and use," the Financial Times reports.